Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002016083 | SCV002299442 | uncertain significance | not provided | 2022-03-22 | criteria provided, single submitter | clinical testing | Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Tolerated"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. This sequence change replaces proline, which is neutral and non-polar, with serine, which is neutral and polar, at codon 1588 of the TUBGCP6 protein (p.Pro1588Ser). This variant is present in population databases (rs778198550, gnomAD 0.0009%). This variant has not been reported in the literature in individuals affected with TUBGCP6-related conditions. |
Ambry Genetics | RCV002545537 | SCV003673334 | uncertain significance | Inborn genetic diseases | 2022-12-14 | criteria provided, single submitter | clinical testing | The c.4762C>T (p.P1588S) alteration is located in exon 21 (coding exon 21) of the TUBGCP6 gene. This alteration results from a C to T substitution at nucleotide position 4762, causing the proline (P) at amino acid position 1588 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |